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Abstract
Background: Pseudothrombocytopenia (PTCP) is a phenomenon of falsely low platelet count
associated with in vitro platelet agglutination due to EDTA-dependent anti-platelet antibodies.
The aim of this study was to determine EDTA-dependent pseudothrombocytopenia frequency in
blood donors and the characteristics of EDTA-dependent anti-platelet antibodies in PTCP donors.
Material and methods: Between January 2001 and August 2008, platelet count was routi-
nely measured in 83.486 unselected Polish blood donors. EDTA-dependent anti-platelet anti-
bodies were detected by using the platelet immunofluorescence test (PIFT).
Results: PTCP was diagnosed in 12 healthy donors. In EDTA samples, the average number
of platelets was 66.8 × 109/l (SD ± 30.8 × 109/l ) and 209.9 × 109/l (SD ± 46.6 x 109/l) in
citrate samples. EDTA-dependant IgG and IgM class antibodies were found in the sera of
10 donors. In 2 donors, PTCP diagnosis was based only on the differences between platelet
counts in EDTA and in citrate samples.
Conclusion: The PTCP frequency in blood donors was calculated at 1:6957, that is 0.014%.
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Streszczenie
Wstęp: Pseudotrombocytopenia (PTCP) jest zjawiskiem polegającym na fałszywym obniże-
niu liczby płytek krwi in vitro spowodowanym aglutynacją płytek przez przeciwciała przeciw-
płytkowe EDTA-zależne. Celem badań była ocena częstości występowania pseudotrombocyto-
penii EDTA-zależnej u dawców krwi i charakterystyka przeciwciał przeciwpłytkowych EDTA-
-zależnych u dawców z PTCP.
Materiał i metody: W okresie od stycznia 2001 do sierpnia 2008 roku zmierzono w bada-
niach rutynowych liczbę płytek krwi u 83 486 nieselekcjonowanych polskich dawców krwi.
Przeciwciała przeciwpłytkowe EDTA-zależne były wykrywane przy użyciu testu immunoflu-
orescencyjnego z płytkami (PIFT).
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Introduction
Pseudothrombocytopenia (PTCP) is a pheno-
menon of spuriously falsely low platelet count as-
sociated with in vitro platelet agglutination. This
results from the presence of anti-platelet antibodies
reacting with platelets in blood drawn into EDTA.
The most likely hypothesis is that such autoanti-
bodies result from the natural elimination of aged
or damaged platelets [1, 2]. These autoantibodies
were shown to be directed against the GPIIb subu-
nit of the platelet membrane [3].
The PTCP phenomenon has mainly been re-
cognized in patients and, less commonly, in heal-
thy subjects undergoing routine blood counts [4, 5].
So far, only two cases of PTCP in blood donors have
been reported [6].
This study presents the frequency of PTCP in
Polish blood donors and the characteristics of EDTA-
dependent anti-platelet antibodies in their sera.
 Material and methods
Between January 2001 and August 2008, we ro-
utinely measured the platelet count in 83.486 unse-
lected Polish blood donors by using a Cell-Dyn 1700
counter, as well as blood anticoagulated with 5%
K2EDTA (Vacutainer, Sarstedt). Pseudothrombocy-
topenia was suspected in donors with a platelet count
below 100 × 109/l and no evidence of bleeding or pur-
pura. To confirm the PTCP diagnosis, the following
two steps were carried out: 1/ the platelet count was
simultaneously examined both in EDTA blood sam-
ples and trisodium citrate blood samples, 2/ EDTA-
dependent anti-platelet antibodies were detected by
using the indirect platelet immunofluorescence test
(PIFT) with FITC-labeled rabbit antiglobulin conju-
gates against human IgG and IgM [7]. The PIFT re-
sults were evaluated by flow cytometry (FACS Cali-
bur, CellQuest TM Software, Becton Dickinson).
To rule out essential thrombocytopenia in
PTCP donors, the specific antiplatelet antibodies in
MAIPA (Monoclonal Antibody Specific Immobiliza-
tion of Platelet Antigen) with mouse monoclonal
antibody immobilization of platelet glycoprotein
(GP): GPII/IIIa (CD41), GPIb (CD42b), GP Ia/IIa
(CD49b) were determined [8].
A four year follow-up was performed on 2 do-
nors. A trace back was performed in 7 recipients of
FFP from PTCP donors.
Results and discussion
Pseudothrombocytopenia was diagnosed in
12 healthy donors; 11 males and 1 female (median age
36, range 18-57 years) with eleven of them being mul-
tiple donors. PTCP donor characteristics are presen-
ted in Table 1. The average number of platelets in
EDTA samples was 66.8 × 109/l (SD ± 30.8 × 109/l)
and 209 × 109/l (SD ± 46.6 × 109/l) in citrate samples.
Our study based on 83,486 routine blood co-
unts, indicates that the PTCP frequency in blood
donors was 1: 6957, i.e. 0.014%.
Although EDTA-dependent IgG and IgM class
antibodies were determined in the sera of 10 do-
nors, in 2 of them only IgM antibodies were detec-
ted four years ago (tab. 2). No platelet antibodies
were observed in two donors (nos. 11 and 12)
while the PTCP diagnosis was based on the diffe-
rences between platelet counts in EDTA and in ci-
trate samples. However, in four donors (nos. 1, 2,
9 and 10) the anti-platelet antibodies were found
also to agglutinate platelets in citrate-anticoagula-
ted blood. In such cases, the real platelet count
should be determined in blood collected into ano-
ther anticoagulant, such as heparin. Trisodium
citrate is known to have a chelating effect on cal-
cium ions, but to a lesser extent than EDTA [9].
Bizzaro et al. [2] reported that the antibodies that
clump platelets in citrate are almost always of IgM
Wyniki: Pseudotrombocytopenia była zdiagnozowana u 12 zdrowych dawców. W próbkach
krwi pobranych na EDTA, średnia liczba płytek była 66,8 × 109/l (SD ± 30,8 × 109/l) i 209,9 ×
× 109/l (SD ± 46,6 × 109/l) w próbkach pobranych na cytrynian. Przeciwciała EDTA-zależne
klas IgG i IgM były stwierdzone w surowicach 10 dawców. U 2 dawców, diagnostyka PTCP
opierała się tylko na różnicy w liczbie płytek krwi pobranych na EDTA i cytrynian.
Wniosek: PTCP u dawców krwi występowała z częstością 1:6957, to znaczy u 0,014%.
Słowa kluczowe: pseudotrombocytopenia, przeciwciała przeciwpłytkowe EDTA-zależne,
dawcy krwi
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type. All our PTCP donors had IgM antibodies but
only in four cases the antibodies reacted in citrate.
In all donors, EDTA-dependent anti-platelet
antibodies agglutinated the platelet at 4oC; in five
donors however (nos. 1, 6, 8, 9, 10), the antibodies
also reacted at 37oC. The follow-up study revealed
that after 4 years, EDTA-dependant antibodies
were still present in two donors (no. 1, no. 2).
No platelet specific antibodies (anti-HPA) were
found in the donor sera.
Pseudoleukocytosis was observed in five do-
nors (nos. 6, 7, 9, 10, 12); the white blood cells were
from 10.5–17.7 × 109/l. In all these cases, a false
increase of the white cell count was caused by
clumps of platelets identified as white cells by au-
tomated instruments [10]. In clinical practice, it is
crucial to know that pseudothrombocytopenia do-
nors may have a higher leukocyte count which is of
no clinical significance.
All the PTCP donors had donated blood 187
times. No post-transfusion reactions were reported
for the recipients of blood from PTCP donors.
A trace back was performed in 7 recipients of FFP
from donors with EDTA-dependant antibodies. No
Table 1. Characteristics of PTCP blood donors
Tabela 1. Charakterystyka dawców krwi z PTCP
Donor no. Sex Age (years) Platelet count (× 109/l) WBC count Number of blood
EDTA Citrate  (× 109/l) donations
1 M 46 30 203 Normal range 6
2 M 18 82 190 Normal range 1
3 M 48 67 162 Normal range 27
4 F 33 63 127 Normal range 4
5 M 24 92 231 Normal range 5
6 M 45 126 310 12.5 19
7 M 33 81 189 17.7 27
8 M 24 66 231 Normal range 27
9 M 38 79 263 12.6 3
10 M 41 19 206 10.5 32
11 M 57 25 206 Normal range 33
12 M 32 48 201 10.8 3
Table 2. Characteristics of EDTA-dependent anti-platelet antibodies
Tabela 2. Charakterystyka przeciwciał przeciwpłytkowych EDTA-zależnych
Donor no. Class of anti-platelet Temperature Agglutination in
antibodies of reactivity  anticoagulants
37oC 4oC EDTA Citrate
1 IgM after 4 years IgG + IgM + – + + + + + –
2 IgM after 4 years IgG + IgM – – + + + + + +
3 IgG + IgM – + + –
4 IgG + IgM – + + –
5 IgG + IgM – + + –
6 IgG + IgM + + + –
7 IgG + IgM – + + –
8 IgG + IgM + + + –
9 IgG + IgM + + + +
10 IgG + IgM + + + +
11 Not detected
12 Not detected
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decrease of platelet count was observed in any of
them. It is worth noting that at the same time, all reci-
pients were transfused FFP not only from PTCP
donors but also from non PTCP donors (2–4 units
of FFP). Thus, the EDTA-dependent antibodies
may have been diluted in the recipient’s blood. In
the literature, we found only one report concerning
the transfusion of a single HLA-matched platelet
from a PTCP donor to a recipient performed by
Sweeney et al. [6]. The platelet increment was cou-
nted using EDTA and citrate samples from the reci-
pient and no differences were observed when these
post-transfusion samples remained for 2 hours at
room temperature.
Conclusions
Pseudothrombocytopenia frequency in Polish
blood donors was determined at 0.014%. EDTA-
-dependent antibodies were of IgG and IgM type.
Transfusion of FFP containing these antibodies
had no effect on the recipient platelet count, as re-
vealed in the trace back.
In PTCP donors, the platelet count should be
examined in citrate blood or another anticoagulant.
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